LiceFreee AfterLice Spray

Manufacturer
Tec Laboratories Inc.
Effective date
2024-11-05
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:34:16

Label at a glance#

ProductLicefreee AfterLice
Active ingredientPRAMOXINE HYDROCHLORIDE
Label structure12 sections

Storage and handling

Other Information Store at 59-86ºF (15-30ºC)

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient

Pramoxine HCI 1%

WARNINGS SECTION

For external use only

OTC - WHEN USING SECTION

When using this product

  • avoid contact with eyes

OTC - STOP USE SECTION

Stop use and ask a doctor if

  • condition worstens
  • symptoms last more than 7 days or clear up and occur again within a few days

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

  • If swallowed, get medical help or contact a Poison Control Center right away.

STORAGE AND HANDLING SECTION

Other Information

Store at 59-86ºF (15-30ºC)

INACTIVE INGREDIENT SECTION

Inactive ingredients

alcohol, benzethonium CI, menthol, panthenol, polyoxyl 35 castor oil, polyquaternium-10, purified water, tea tree oil

OTC - QUESTIONS SECTION

Questions or comments?

Call 1-800-482-4464.

INDICATIONS & USAGE SECTION

Uses

for the temporary relief of itching associated with

  • insect bites
  • minor skin irritations

DOSAGE & ADMINISTRATION SECTION

Directions

  • Adults and children 2 years of age and older: spray on affected area not more than 3-4 times daily
  • Children under 2 years; do not use; consult a doctor

OTC - PURPOSE SECTION

Pain and itch relief spray for scalp irritation caused by lice bites and lice treatments.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Licefreee AfterLiceLicefreee AfterLice

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1294036pramoxine HCl 1 % Topical SprayPSN2
1294036pramoxine hydrochloride 10 MG/ML Topical SpraySCD2
1294036pramoxine hydrochloride 1 % Topical SpraySY2

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3c386306-c48a-413e-bb69-70cb268496f3Product name120210727
7792dadb-52b6-46b6-8fdf-80b1171065b5Product name120180810
58f3f9b7-3b9b-a9c1-1c9f-18ac777192b8Product name120140508
a7051cba-790b-a699-81f8-dbbbdbd9b5acProduct name120140508
da108d9e-edc8-17a3-8c28-3251c6a8acccProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51879-260-06Licefreee AfterLice177.4 g in 1 BOTTLE, PLASTICSPRAY177.42

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51879-260LICEFREEE AFTERLICE (PRAMOXINE HCI) SPRAY [TEC LABORATORIES INC.]2Current NDC, 1 package rows20241107_06c4cc42-a215-3949-e063-6394a90a665e.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
51879-26051879-260-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Licefreee AfterLicePRAMOXINE HCITec Laboratories Inc.06c4cc42-a215-3949-e063-6394a90a665e2024-11-05WarningsExact identifier
ndc (package): 51879-260-06
ndc (product): 51879-260
ndc11 (package): 51879026006
spl id: 262f50ab-fd53-7474-e063-6394a90a4f40
spl set id: 06c4cc42-a215-3949-e063-6394a90a665e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.